Table of Content




1. Executive Summary


2. Global Pharmacovigilance Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pharmacovigilance Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Pharmacovigilance Market by Therapeutic Area
3.3.1: Oncology
3.3.2: Neurology
3.3.3: Cardiology
3.3.4: Respiratory Systems
3.3.5: Others

3.4: Global Pharmacovigilance Market by Process Flow
3.4.1: Case Data Management
3.4.2: Signal Detection
3.4.3: Risk Management Systems

3.5: Global Pharmacovigilance Market by Service Provider
3.5.1: In-House
3.5.2: Contract Outsourcing

3.6: Global Pharmacovigilance Market by End Use
3.6.1: Pharmaceuticals
3.6.2: Biotechnology Companies
3.6.3: Medical Device Manufacturers
3.6.4: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pharmacovigilance Market by Region
4.2: North American Pharmacovigilance Market
4.2.1: North American Pharmacovigilance Market by Therapeutic Area: Oncology, Neurology, Cardiology, Respiratory Systems, and Other
4.2.2: North American Pharmacovigilance Market by End Use: Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others

4.3: European Pharmacovigilance Market
4.3.1: European Pharmacovigilance Market by Therapeutic Area: Oncology, Neurology, Cardiology, Respiratory Systems, and Others
4.3.2: European Pharmacovigilance Market by End Use: Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others

4.4: APAC Pharmacovigilance Market
4.4.1: APAC Pharmacovigilance Market by Therapeutic Area: Oncology, Neurology, Cardiology, Respiratory Systems, and Others
4.4.2: APAC Pharmacovigilance Market by End Use: Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others

4.5: ROW Pharmacovigilance Market
4.5.1: ROW Pharmacovigilance Market by Therapeutic Area: Oncology, Neurology, Cardiology, Respiratory Systems, and Others
4.5.2: ROW Pharmacovigilance Market by End Use: Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pharmacovigilance Market by Therapeutic Area
6.1.2: Growth Opportunities for the Global Pharmacovigilance Market by Process Flow
6.1.3: Growth Opportunities for the Global Pharmacovigilance Market by Service Provider
6.1.4: Growth Opportunities for the Global Pharmacovigilance Market by End Use
6.1.5: Growth Opportunities for the Global Pharmacovigilance Market by Region

6.2: Emerging Trends in the Global Pharmacovigilance Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pharmacovigilance Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmacovigilance Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Accenture
7.2: Cognizant
7.3: Clinquest Group
7.4: IBM
7.5: ArisGlobal
7.6: Capgemini
7.7: ICON